John Hohneker - Net Worth and Insider Trading

John Hohneker Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Hohneker owns 4 companies in total, including Curis Inc (CRIS) , Humanigen Inc (HGENQ) , and Aravive Inc (ARAV) among others .

Click here to see the complete history of John Hohneker’s form 4 insider trades.

Insider Ownership Summary of John Hohneker

Ticker	Comapny	Transaction Date	Type of Owner
CRIS	Curis Inc	2023-01-23	director
HGENQ	Humanigen Inc	2021-10-19	director
ARAV	Aravive Inc	2021-05-12	director
		2021-01-27	director

John Hohneker Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

John Hohneker Ownership Network

Ownership Network List of John Hohneker

No Data

Ownership Network Relation of John Hohneker

John Hohneker Owned Company Details

What does Curis Inc do?

Who are the key executives at Curis Inc?

John Hohneker is the director of Curis Inc. Other key executives at Curis Inc include CDO Jonathan B. Zung , CFO Diantha Duvall , and director & President & CEO James E Dentzer .

Curis Inc (CRIS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Curis Inc (CRIS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Curis Inc (CRIS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Curis Inc (CRIS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Curis Inc Insider Transactions

No Available Data

What does Humanigen Inc do?

Who are the key executives at Humanigen Inc?

John Hohneker is the director of Humanigen Inc. Other key executives at Humanigen Inc include 10 percent owner Dale Chappell , Chief Medical Officer Adrian Kilcoyne , and Chief Commercial Officer Edward P. Jordan .

Humanigen Inc (HGENQ) Insider Trades Summary

Over the past 18 months, John Hohneker made no insider transaction in Humanigen Inc (HGENQ). Other recent insider transactions involving Humanigen Inc (HGENQ) include a net sale of 386,350 shares made by Dale Chappell ,

In summary, during the past 3 months, insiders sold 0 shares of Humanigen Inc (HGENQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 386,350 shares of Humanigen Inc (HGENQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 386,350 shares.

Humanigen Inc (HGENQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

Humanigen Inc Insider Transactions

No Available Data

What does Aravive Inc do?

Who are the key executives at Aravive Inc?

John Hohneker is the director of Aravive Inc. Other key executives at Aravive Inc include Chief Commercial Officer Maria Carolina Petrini , Chief Medical Officer Robert B. Geller , and Chief Financial Officer Rudy Howard .

Aravive Inc (ARAV) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Aravive Inc (ARAV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aravive Inc (ARAV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aravive Inc (ARAV)'s detailed insider trading history can be found in Insider Trading Tracker table.

Aravive Inc Insider Transactions

No Available Data

What does Evelo Biosciences Inc do?

Who are the key executives at Evelo Biosciences Inc?

John Hohneker is the director of Evelo Biosciences Inc. Other key executives at Evelo Biosciences Inc include Chief Medical Officer Duncan Mchale , Chief Financial Officer Marella Thorell , and See Remarks Mark Bodmer .

Evelo Biosciences Inc (EVLO) Insider Trades Summary

Over the past 18 months, John Hohneker made no insider transaction in Evelo Biosciences Inc (EVLO). Other recent insider transactions involving Evelo Biosciences Inc (EVLO) include a net sale of 35,716 shares made by Mark Bodmer , a net sale of 13,391 shares made by Duncan Mchale , and a net sale of 7,814 shares made by Marella Thorell .

In summary, during the past 3 months, insiders sold 0 shares of Evelo Biosciences Inc (EVLO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 37,989 shares of Evelo Biosciences Inc (EVLO) were sold and 5,411,255 shares were bought by its insiders, resulting in a net purchase of 5,373,266 shares.

Evelo Biosciences Inc (EVLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Evelo Biosciences Inc Insider Transactions

No Available Data

John Hohneker Mailing Address

Above is the net worth, insider trading, and ownership report for John Hohneker. You might contact John Hohneker via mailing address: C/o Dimension Therapeutics, Inc., 840 Memorial Drive 4th Floor, Cambridge Ma 02139.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.